NEOADJUVANT CHEMOIMMUNOTHERAPY
Clinical trials for NEOADJUVANT CHEMOIMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT CHEMOIMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT CHEMOIMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common heart drug boost colon cancer treatment?
Disease control Not yet recruitingThis study tests whether adding a beta-blocker (propranolol) to a standard immunotherapy and chemotherapy combination before surgery can improve outcomes for people with locally advanced colon cancer. About 45 participants will receive either the standard combination or the combi…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Simple bike test could predict lung cancer surgery risks
Knowledge-focused Not yet recruitingThis study looks at whether a simple, low-intensity cycling test can help predict serious complications in people being treated for lung cancer. Researchers will measure carbon dioxide levels with a handheld device during exercise. The goal is to make risk assessment easier and m…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated May 17, 2026 02:38 UTC